All-or-nothing treatment targets make bad performance measures

American Journal of Managed Care

Volumn 13, Issue 3, 2007, Pages 126-128

  Hayward, Rodney A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN; METFORMIN; SULFONYLUREA;

BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; COMORBIDITY; DIABETES MELLITUS; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HUMAN; MANAGED CARE; MONOTHERAPY; MORTALITY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; INSULIN; MALE; MANAGED CARE PROGRAMS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY INDICATORS, HEALTH CARE; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 33947230609     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Pogach LM, Tiwari A, Maney M, Rajan M, Miller DR, Aron D. Should mitigating comorbidities be considered in assessing Healthcare plan performance in achieving optimal glycemic control. Am J Manag Care. 2007;13:133-140.
2. Pogacli LM, Rajan M, Aron DC. Comparison of weighted performance measurement and dichotomous thresholds for glycemic control in the Veterans Health Administration. Diabetes Care. 2006;29: 241-246.
3. Kerr EA, Krein SL, Vijan S. Hofer TP, Hayward RA. Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of technical quality measures. Am J Manag Care. 2001;7:1033-1043.
4. Kerr EA, Smith DM, Hogan MH, et al. Building a better quality measure: are some patients with "poor quality" actually getting good care? Med Care. 2003;41:1173-1182.
5. O'Malley AS, Clancy C, Thompson J, Korabathina R, Meyer GS. Clinical practice guidelines and performance indicators as related-but often misunderstood-tools. Jt Comm J Qual Saf. 2004;30:163-171.
6. S. Hayward RA, Hofer TP, Kerr EA, Krein SL. Quality improvement initiatives: issues in moving from diabetes guidelines to policy. Diabetes Care. 2004;27(suppl 2):B54-B60.
7. Hofer TP, Hayward RA, Greenfiald S, Wagner EH, Kaplan SH, Manning WG. The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease. JAMA. 1999;281:2098-2105.
8. Rosenberg AL, Hofer TP, Strachan C, Watts CM, Hayward RA. Accepting critically ill transfer patients: adverse effect on a referral center's outcome and benchmark measures. Ann Intern Med. 2003;138: 882-890.
9. S. Hayward RA, Hofer TP, Vijan S. Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem. Ann Intern Med. 2006;145:520-530.
10. Hayward RA, Kent DM, Vijan S, Hofer TP. Reporting clinical trial results to inform clinical providers, payers and consumers. Health Aff (Millwood). 2005;24:1571-1581.
11. McMahon LF, Hayward RA, Saint S, Chemew ME, Fendrick AM. Univariate solutions in a multivariate world: can we afford to practice as in the "good old days"? Am J Manag Care. 2005;11:473-476.
12. Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med. 1997;127:837-839.
13. Vijan S, Hayward RA. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med. 2003;138:593-602.
14. H. L. Mencken Quotes. Available at: http://www.brainyquote.com/ quotes/h/hlmencke162005.html. Accessed February 20, 2007.
15. National Diabetes Quality Improvement Alliance. Available at: http://www.nationaldiabetesalliance.org/organizations.html. Accessed February 9, 2007.
16. Messerli FH, Giuseppe Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144: 884-893.
17. Vijan S, Kent DM, Hayward RA. Are randomized controlled trials sufficient evidence to guide clinical practice in type II (non-insulin dependent) diabetes mellitus? Diabetologia. 2000;43:125-130.
18. Shaughnessy AF, Slawson DC. What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetes. BMJ. 2003;327:266.
19. Asch SM, McGlynn EA, Hogan MM, et al. Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med. 2004;141:938-945.